MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells
about
Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)Genomic alterations in breast cancer patients in betel quid and non betel quid chewersAdipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 PathwayMUC16 (CA125): tumor biomarker to cancer therapy, a work in progressCCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck.MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expressionJanus kinase 2 polymorphisms are associated with risk in patients with gastric cancer in a Chinese population.MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signalingPathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancersMucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinomaEmerging potential of natural products for targeting mucins for therapy against inflammation and cancer.Genetically engineered mucin mouse models for inflammation and cancer.The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism.Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?C-terminus of MUC16 activates Wnt signaling pathway through its interaction with β-catenin to promote tumorigenesis and metastasis.Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.Advances in miRNA-Mediated Mucin Regulation.Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets.JAK2 inhibition for the treatment of hematologic and solid malignancies.Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.Cellular and molecular biology of airway mucins.Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy.Generation and characterization of a monoclonal antibody to the cytoplasmic tail of MUC16.Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer.Protocol for Apoptosis Assay by Flow Cytometry Using Annexin V Staining Method.Allelic expression imbalance polymorphisms in susceptibility chromosome regions and the risk and survival of breast cancer.AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics.MicroRNA-7-5p mediates the signaling of hepatocyte growth factor to suppress oncogenes in the MCF-10A mammary epithelial cell.NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.
P2860
Q26739942-672A626E-8BDD-42CE-AE97-AE7EEE5D13C8Q28482521-27952D0C-A1BC-4249-9D5C-A3989AED15EBQ33584044-253E5442-6947-41ED-A029-740A7F98944CQ33713506-106A39EA-20B7-43C4-9B37-D300C676B90FQ34487441-704B0AB2-2CF6-4683-B503-91EA451AD478Q34524741-2A2E89F8-528D-4F26-ADD9-08271ABCA7ADQ34746150-2E62CE3A-0735-42CE-AFA8-44A0C1041137Q34991249-FB3DC306-BA8C-4624-BCE0-3F79D3A4DC11Q35145588-D5F6AEE6-371B-4105-AED0-6FF995575E66Q35677625-E08D7B22-FB46-4AA9-8AAC-7299A7D5B15BQ35732689-A203E9C8-5876-4478-A779-537163BDB49EQ35749993-68AF1A82-56DC-47AE-A2BC-5F2D90F6DA65Q35904634-A48002E5-960E-4A67-B14E-9B659D36C0E2Q36016491-3E09E752-23F2-42E3-9ED0-6CDB80E3EC3EQ36057627-0F4D50D4-0A43-4B89-B26F-5E0A3A6D9AB0Q36109029-5CE4FD13-0930-494E-B656-2A7D6143A4C0Q36328299-AF00E0A1-1221-4106-902F-E0FC451C7CC7Q36413160-E07B0DE7-8231-4299-A238-2D89BC63DBE2Q37033307-38F8236E-3AAD-4A4F-9466-E32162553762Q37301771-CFC5DEF6-2CD7-4829-81D2-218880BDCBECQ37392837-78ED2897-C25D-447D-B7CB-B6401BB8C6E6Q37415839-806458D5-BF5C-48F7-B114-F974A56FE64DQ37420793-721EF78D-2DAB-42C5-B5A8-811198FE34E2Q37605645-038D96BD-278D-4FC5-B474-F060FC6D01FBQ38001733-EE576297-F026-4551-A443-CE0B4EAFE3F7Q38035209-D5E9C222-230D-4E57-8913-0E3B8BBF859CQ38085109-E97C9294-8B9B-4E10-9981-78ED4BA2CABCQ38623057-0A047E1B-9205-4FBF-B4D1-E4F954B33B70Q38698224-352431C6-F4E8-4419-A529-1B8CAB9350E9Q38724921-81A9E5F6-6D46-427C-BD05-C0960C11790FQ38804960-1C9EA574-0A6A-4F21-A388-7BD8533D08DFQ38908575-A618B8D5-D230-44DE-8447-2F925DB00E33Q39067183-725F99E2-08E4-4BB5-8253-844B238735B3Q39589151-B45AF87B-34FA-4AB3-B3E2-0C488CE1AF11Q40775934-BDB07076-3280-46C3-9097-0E1B17A5DF8BQ41717314-DCDB310C-E50D-4010-9419-6D53695471B0Q47107336-C6A2E236-FE7E-4535-B7F8-C8291CCCBFBCQ50786022-A460EA69-AF96-4F69-B57E-486AC34CDDC0Q51138004-57A7C81F-11C5-490D-A55F-E58FF785F25AQ51706809-CFDF75C5-834E-4407-BAF5-91A4F9802F6E
P2860
MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MUC16 induced rapid G2/M trans ...... optosis in breast cancer cells
@ast
MUC16 induced rapid G2/M trans ...... optosis in breast cancer cells
@en
type
label
MUC16 induced rapid G2/M trans ...... optosis in breast cancer cells
@ast
MUC16 induced rapid G2/M trans ...... optosis in breast cancer cells
@en
prefLabel
MUC16 induced rapid G2/M trans ...... optosis in breast cancer cells
@ast
MUC16 induced rapid G2/M trans ...... optosis in breast cancer cells
@en
P2093
P2860
P356
P1433
P1476
MUC16 induced rapid G2/M trans ...... optosis in breast cancer cells
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.297
P407
P577
2011-07-25T00:00:00Z